A mage accidentally drifts to Blue Star. The intelligent life on Blue Star cannot influence reality by manipulating dark matter, thus the mage loses their casting ability.
In order to recover...
"I just want to know the price, nothing else. I don't know if I have enough money. If not, I'll have to borrow from someone."
Most consumers don't care about the significance of a product, its impact on the social situation and macroeconomy, or which industries might disappear or be created in the future.
These are important, but they are meaningless to consumers.
Only when their own interests are affected do they belatedly realize that the product launch of that year actually signified the end of an era and the arrival of a new one.
When Steve Jobs held up the iPhone at an Apple launch event, the audience certainly didn't realize that this thing would render traditional mobile phones obsolete in just a few years.
When Microsoft released its Windows operating system, no one could have imagined that it would profoundly impact everyone's lives over the next few decades.
The same applies today. The audience in the audience and consumers in front of the screen are only concerned about two things: the user experience and the price.
In fact, thanks to Lei Jun's rice promotion over the past ten years, ordinary users in China are very concerned about performance parameters.
Let's run a benchmark test and see what happens.
As a result, Xiaomi directly acquired the benchmarking software AnTuTu.
The problem is that it's impossible to run benchmarks for a biological computer device, and there's not even a comparable object on Earth.
The completely white virtual reality organism has no interfaces whatsoever; you can connect it to your computer to run benchmarks.
Moreover, it's uncertain whether benchmarking software can accurately predict future scores.
After all, benchmarking software also has its limits.
"I want to know if my hunger in the real world, or in the virtual world, will be transmitted synchronously to the real world."
"It really is a virtual reality device that can synchronize the five senses. This press conference can be said to mean that all brain-computer interface VR devices on Earth can now be retired from the stage of history."
"Is this the sense of destiny in history? The VR era was started by scientific and technological innovations, and it will also end with scientific and technological innovations."
"This is not the end of VR, but a new beginning. The full name of VR in English is virtual reality."
Kechuang Bio has taken virtual reality a giant leap forward once again.
Whether it's developed countries like America, the Europa League, Japan, and Korea, or developing countries like China, or even underdeveloped countries, people of different nationalities, skin colors, and languages are all expressing their opinions on various social media platforms.
So far, only a few countries have reached agreements to import virtual reality equipment; these include developed countries and a few developing countries.
The difference is not due to any preference between countries by the biotech company, but rather to the cognitive biases of the executives who lead the business negotiations.
This is a ingrained way of thinking; in their view, developed countries and developing countries that are doing relatively well obviously have better purchasing power and higher-quality consumers.
As for underdeveloped countries, people at the bottom of society are already struggling to make a living, let alone have the extra funds to buy virtual reality equipment.
Even the people of these countries often lack the funds to build a nationwide biocommunication tree.
It can't be like how China's infrastructure projects are promoted overseas, where Kechuang Bio provides them with an interest-free loan, and then the other party uses this interest-free loan to purchase bio-communication engineering.
This is a losing proposition made in order to increase influence.
Moreover, it may not necessarily increase influence, and the interest-free loan may even turn into a subsidized loan, or even into a debt relief.
This happens from time to time.
As a nation, China can sometimes disregard economic interests for strategic reasons, but this is not the case for science and technology innovation companies.
Or rather, the executives at Kechuang Biotechnology could not tolerate this happening.
"The 'Future' we are selling only comes in white and green. I personally prefer white. It is best for users not to dye it themselves after purchase. We will not be responsible for any negative effects caused by dyeing."
Kechuang Bio provides a matching nutrient solution. You can buy the nutrient solution about once every six months and then soak the future product in the nutrient solution for a day.
Then, aside from the time spent cultivating in the nutrient solution, simply place 'Future' under light.
"Due to production capacity limitations, the first batch of goods can only be produced in one million units, and they will be distributed to countries all over the world."
It's still quite difficult to get one.
However, there's no need to worry. We anticipate that we can meet global demand in about six months.
Production capacity cannot be increased at will.
Moreover, all of our current production bases are located in Suzhou, and we also produce bio-communication trees.
Kechuang Bio has stopped producing endorphins, and all skilled workers have been transferred to a production base that will also house bio-communication equipment in the future.
"There are only one million, and it is estimated that only about 200,000 will be allocated to China. Suzhou alone can absorb all 200,000."
"The scalpers are ecstatic! Just one scalper can bring in tens of thousands in profit. They're going to make a killing!"
"Scalpers are not a big deal, the real problem is when executives of Kechuang Bio collude with scalpers to sell at inflated prices. That's the most disgusting thing."
"Buy early and enjoy early, buy late and get a discount."
“The insufficient production capacity is understandable, after all, it was only announced at the beginning of this year that there was no upstream or downstream supply chain, and Kechuang Bio was fighting on its own. It is already very difficult to have a production capacity of one million.”
This chapter is not finished, please click the next page to continue reading!